首页 > 最新文献

Tropical Diseases, Travel Medicine and Vaccines最新文献

英文 中文
Cardioembolic stroke in Chagas disease: unraveling the underexplored connection through a systematic review. 南美锥虫病引发的心栓塞性中风:通过系统回顾揭示未充分探索的关联。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2024-09-01 DOI: 10.1186/s40794-024-00227-y
Jorge Vásconez-González, Camila Miño, Juan S Izquierdo-Condoy, Camila Salazar-Santoliva, Andrés López-Cortés, Esteban Ortiz-Prado

Background: Chagas disease (CD), triggered by the Trypanosoma cruzi parasite, is originally endemic across Latin America, affecting millions. While cardiac complications are widely recognized, the association between CD and stroke remains underexplored. This systematic review aims to elucidate the relationship between CD and stroke, highlighting the cardioembolic origins of stroke in CD patients and assessing the elevated stroke risk compared to non-infected individuals.

Methodology: Adhering to the PRISMA guidelines, we conducted a comprehensive search in PubMed and Scopus databases without date restrictions, including articles in both Spanish and English. This approach enabled the identification and analysis of relevant studies to understand the interplay between CD and stroke risk.

Results: Our analysis of 25 selected studies indicates that strokes in CD patients predominantly arise from cardioembolic sources. The data underscore a significant increase in stroke risk among individuals infected with T. cruzi compared to uninfected counterparts. Additionally, CD patients face a higher stroke and mortality risk than those with other heart failure etiologies, irrespective of disease severity.

Conclusion: The review establishes CD as a critical contributor to stroke incidence, emphasizing the need for heightened awareness and diagnosis of CD in stroke patients, particularly in regions with high CD prevalence. Recognizing the increased stroke risk associated with T. cruzi infection is crucial for developing targeted educational and preventive strategies in endemic areas.

背景:南美锥虫病(CD)是由南美锥虫引发的,最初在拉丁美洲流行,影响数百万人。虽然心脏并发症已被广泛认识,但 CD 与中风之间的关系仍未得到充分探讨。本系统综述旨在阐明 CD 与中风之间的关系,强调 CD 患者中风的心栓塞起源,并评估与未感染者相比中风风险的升高:根据 PRISMA 指南,我们在 PubMed 和 Scopus 数据库中进行了全面搜索,没有日期限制,包括西班牙语和英语文章。这种方法有助于识别和分析相关研究,以了解 CD 与中风风险之间的相互作用:结果:我们对所选的 25 项研究进行的分析表明,CD 患者的中风主要源于心肌栓塞。这些数据表明,与未感染的同类患者相比,感染了 T. cruzi 的患者中风风险明显增加。此外,与其他心衰病因的患者相比,无论疾病严重程度如何,CD 患者都面临着更高的中风和死亡风险:本综述将 CD 定义为中风发病率的一个重要因素,强调需要提高中风患者对 CD 的认识和诊断,尤其是在 CD 高发地区。认识到与 T. cruzi 感染相关的中风风险增加对于在疾病流行地区制定有针对性的教育和预防策略至关重要。
{"title":"Cardioembolic stroke in Chagas disease: unraveling the underexplored connection through a systematic review.","authors":"Jorge Vásconez-González, Camila Miño, Juan S Izquierdo-Condoy, Camila Salazar-Santoliva, Andrés López-Cortés, Esteban Ortiz-Prado","doi":"10.1186/s40794-024-00227-y","DOIUrl":"10.1186/s40794-024-00227-y","url":null,"abstract":"<p><strong>Background: </strong>Chagas disease (CD), triggered by the Trypanosoma cruzi parasite, is originally endemic across Latin America, affecting millions. While cardiac complications are widely recognized, the association between CD and stroke remains underexplored. This systematic review aims to elucidate the relationship between CD and stroke, highlighting the cardioembolic origins of stroke in CD patients and assessing the elevated stroke risk compared to non-infected individuals.</p><p><strong>Methodology: </strong>Adhering to the PRISMA guidelines, we conducted a comprehensive search in PubMed and Scopus databases without date restrictions, including articles in both Spanish and English. This approach enabled the identification and analysis of relevant studies to understand the interplay between CD and stroke risk.</p><p><strong>Results: </strong>Our analysis of 25 selected studies indicates that strokes in CD patients predominantly arise from cardioembolic sources. The data underscore a significant increase in stroke risk among individuals infected with T. cruzi compared to uninfected counterparts. Additionally, CD patients face a higher stroke and mortality risk than those with other heart failure etiologies, irrespective of disease severity.</p><p><strong>Conclusion: </strong>The review establishes CD as a critical contributor to stroke incidence, emphasizing the need for heightened awareness and diagnosis of CD in stroke patients, particularly in regions with high CD prevalence. Recognizing the increased stroke risk associated with T. cruzi infection is crucial for developing targeted educational and preventive strategies in endemic areas.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"10 1","pages":"16"},"PeriodicalIF":2.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11366139/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Travellers with prosthetic limbs, a neglected population. A perspective on what travel health practitioners need to know. 装有假肢的旅行者,一个被忽视的群体。从旅行保健从业人员需要了解的角度出发。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-15 DOI: 10.1186/s40794-024-00226-z
Irmgard L Bauer, Vikranth H Nagaraja

Background: The benefits of travel for the wellbeing of people of all ages and abilities are well known, though travellers with prostheses have so far been excluded. Limb loss, due to trauma, vascular disease, cancer, or infections requires a prosthesis for cosmesis and functionality. The life-changing event of losing a limb and the considerable psychological adjustment to accept an altered body image influence rehabilitation and self-management as well as the participation in social activities, such as sport and travel. The challenge of travel lies not only in transferring practical impediments encountered at home to another location; familiar coping strategies may require unexpected adjustments. After presenting background information on limb loss and prostheses, the purpose of this paper was to review literature on health advice for travellers with prosthetic limbs.

Method: All major data bases were searched for peer-reviewed literature using a variation of keyword combinations around travel and prosthetics. Relevant journals were searched individually, and selected authors and university departments contacted. No evidence-based results were obtained. The search then moved to grey literature including documents from relevant organisations, professional bodies, government websites, manufacturers, airlines, prosthetic/physiotherapy clinics, sport organisations to approaching amputees, including veterans and athletes, directly.

Result: The list of collated travel advice for people with artificial limbs relates to (1) trip preparation, (2) packing (especially considering the mechanical and/or electrical requirements of the prosthesis), (3) travelling by plane as the most covered mode of travel, and (4) navigating airports and airport security, which may be used by travel health practitioners while awaiting evidence-based guidelines.

Conclusion: This is the first paper on travel with a prosthetic limb in any field, including travel medicine. Therefore, travel health practitioners have no evidence-based guidelines at their disposal required for high-quality care for this neglected population. Preliminary recommendations for clinical practice, advice for required updates in education, and suggestions for urgently needed research are provided to replace current hints and tips with evidence so that travellers with prostheses are no longer 'out on a limb'.

背景:众所周知,旅行对不同年龄、不同能力的人都有好处,但装有假肢的旅行者至今仍被排除在外。由于外伤、血管疾病、癌症或感染导致的肢体缺失,需要安装假肢来保持外观和功能。失去肢体这一改变生活的事件,以及接受身体形象改变所带来的巨大心理调整,都会影响康复和自我管理,以及参与体育和旅行等社会活动。旅行的挑战不仅在于将在家中遇到的实际障碍转移到另一个地方,熟悉的应对策略也可能需要做出意想不到的调整。在介绍了有关肢体缺失和假肢的背景信息后,本文旨在回顾有关为携带假肢的旅行者提供健康建议的文献:方法:使用围绕旅行和假肢的不同关键词组合,在所有主要数据库中搜索同行评审文献。对相关期刊进行了逐一检索,并联系了部分作者和大学院系。未获得任何基于证据的结果。然后转而搜索灰色文献,包括相关组织、专业机构、政府网站、制造商、航空公司、假肢/物理治疗诊所、体育组织的文件,以直接接触截肢者,包括退伍军人和运动员:整理出的假肢使用者旅行建议清单涉及:(1) 旅行准备;(2) 包装(特别是考虑到假肢的机械和/或电气要求);(3) 乘飞机旅行是最常见的旅行方式;(4) 机场和机场安检导航,旅行保健从业人员可在等待循证指南时使用这些建议:结论:这是第一篇关于在任何领域(包括旅行医学)携带假肢旅行的论文。因此,旅行医疗从业人员还没有为这一被忽视的人群提供高质量医疗服务所需的循证指南。本文对临床实践提出了初步建议,对教育中需要更新的内容提出了建议,并对急需开展的研究提出了建议,以便用证据来取代目前的提示和窍门,使携带假肢的旅行者不再 "束手无策"。
{"title":"Travellers with prosthetic limbs, a neglected population. A perspective on what travel health practitioners need to know.","authors":"Irmgard L Bauer, Vikranth H Nagaraja","doi":"10.1186/s40794-024-00226-z","DOIUrl":"10.1186/s40794-024-00226-z","url":null,"abstract":"<p><strong>Background: </strong>The benefits of travel for the wellbeing of people of all ages and abilities are well known, though travellers with prostheses have so far been excluded. Limb loss, due to trauma, vascular disease, cancer, or infections requires a prosthesis for cosmesis and functionality. The life-changing event of losing a limb and the considerable psychological adjustment to accept an altered body image influence rehabilitation and self-management as well as the participation in social activities, such as sport and travel. The challenge of travel lies not only in transferring practical impediments encountered at home to another location; familiar coping strategies may require unexpected adjustments. After presenting background information on limb loss and prostheses, the purpose of this paper was to review literature on health advice for travellers with prosthetic limbs.</p><p><strong>Method: </strong>All major data bases were searched for peer-reviewed literature using a variation of keyword combinations around travel and prosthetics. Relevant journals were searched individually, and selected authors and university departments contacted. No evidence-based results were obtained. The search then moved to grey literature including documents from relevant organisations, professional bodies, government websites, manufacturers, airlines, prosthetic/physiotherapy clinics, sport organisations to approaching amputees, including veterans and athletes, directly.</p><p><strong>Result: </strong>The list of collated travel advice for people with artificial limbs relates to (1) trip preparation, (2) packing (especially considering the mechanical and/or electrical requirements of the prosthesis), (3) travelling by plane as the most covered mode of travel, and (4) navigating airports and airport security, which may be used by travel health practitioners while awaiting evidence-based guidelines.</p><p><strong>Conclusion: </strong>This is the first paper on travel with a prosthetic limb in any field, including travel medicine. Therefore, travel health practitioners have no evidence-based guidelines at their disposal required for high-quality care for this neglected population. Preliminary recommendations for clinical practice, advice for required updates in education, and suggestions for urgently needed research are provided to replace current hints and tips with evidence so that travellers with prostheses are no longer 'out on a limb'.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"10 1","pages":"14"},"PeriodicalIF":2.4,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11325610/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A landscape review of malaria vaccine candidates in the pipeline. 疟疾疫苗候选项目概览。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-01 DOI: 10.1186/s40794-024-00222-3
Yusuf Amuda Tajudeen, Habeebullah Jayeola Oladipo, Sodiq Inaolaji Yusuff, Samuel O Abimbola, Muritala Abdulkadir, Iyiola Olatunji Oladunjoye, Abass Olawale Omotosho, Oluwaseyi Muyiwa Egbewande, Hameedat Damilola Shittu, Rashidat Onyinoyi Yusuf, Oluwatosin Ogundipe, Abdulbasit Opeyemi Muili, Abdullateef Opeyemi Afolabi, Salwa M A Dahesh, Marwa Ahmed Mahmoud Gameil, Mona Said El-Sherbini
<p><strong>Background: </strong>Globally, malaria continues to pose a major health challenge, with approximately 247 million cases of the illness and 627,000 deaths reported in 2021. However, the threat is particularly pronounced in sub-Saharan African countries, where pregnant women and children under the age of five face heightened vulnerability to the disease. As a result, the imperative to develop malaria vaccines especially for these vulnerable populations, remains crucial in the pursuit of malaria eradication. However, despite decades of research, effective vaccine development faces technical challenges, including the rapid spread of drug-resistant parasite strains, the complex parasite lifecycle, the development of liver hypnozoites with potential for relapse, and evasion of the host immune system. This review aims to discuss the different malaria vaccine candidates in the pipeline, highlighting different approaches used for adjuvating these candidates, their benefits, and outcomes, and summarizing the progress of these vaccine candidates under development.</p><p><strong>Method: </strong>A comprehensive web-based search for peer-reviewed journal articles published in SCOPUS, MEDLINE (via PubMed), Science Direct, WHO, and Advanced Google Scholar databases was conducted from 1990 to May 2022. Context-specific keywords such as "Malaria", "Malaria Vaccine", "Malaria Vaccine Candidates", "Vaccine Development", "Vaccine Safety", "Clinical Trials", "mRNA Vaccines", "Viral Vector Vaccines", "Protein-based Vaccines", "Subunit Vaccines", "Vaccine Adjuvants", "Vaccine-induced Immune Responses", and "Immunogenicity" were emphatically considered. Articles not directly related to malaria vaccine candidates in preclinical and clinical stages of development were excluded.</p><p><strong>Results: </strong>Various approaches have been studied for malaria vaccine development, targeting different parasite lifecycle stages, including the pre-erythrocytic, erythrocytic, and sexual stages. The RTS, S/AS01 vaccine, the first human parasite vaccine reaching WHO-listed authority maturity level 4, has demonstrated efficacy in preventing clinical malaria in African children. However, progress was slow in introducing other safe, and feasible malaria vaccines through clinical trials . Recent studies highlight the potential effectiveness of combining pre-erythrocytic and blood-stage vaccines, along with the advantages of mRNA vaccines for prophylaxis and treatment, and nonstructural vaccines for large-scale production.</p><p><strong>Conclusion: </strong>Malaria vaccine candidates targeting different lifecycle stages of the parasite range from chemoprophylaxis vaccination to cross-species immune protection. The use of a multi-antigen, multi-stage combinational vaccine is therefore essential in the context of global health. This demands careful understanding and critical consideration of the long-term multi-faceted interplay of immune interference, co-dominance, complement
背景:在全球范围内,疟疾仍然是一项重大的健康挑战,2021 年报告的疟疾病例约为 2.47 亿例,627,000 人死亡。然而,这一威胁在撒哈拉以南非洲国家尤为明显,那里的孕妇和五岁以下儿童更容易感染疟疾。因此,开发疟疾疫苗,尤其是针对这些易感人群的疫苗,对于根除疟疾仍然至关重要。然而,尽管进行了数十年的研究,有效的疫苗开发仍面临着技术挑战,包括抗药性寄生虫菌株的快速传播、寄生虫复杂的生命周期、具有复发潜力的肝脏下吸虫的发育以及宿主免疫系统的逃避。本综述旨在讨论不同的候选疟疾疫苗,重点介绍用于佐剂这些候选疫苗的不同方法、其益处和结果,并总结这些候选疫苗的研发进展:方法:对 1990 年至 2022 年 5 月期间在 SCOPUS、MEDLINE(通过 PubMed)、Science Direct、WHO 和高级 Google Scholar 数据库中发表的同行评审期刊论文进行了全面的网络检索。重点考虑了 "疟疾"、"疟疾疫苗"、"候选疟疾疫苗"、"疫苗开发"、"疫苗安全性"、"临床试验"、"mRNA 疫苗"、"病毒载体疫苗"、"蛋白质疫苗"、"亚单位疫苗"、"疫苗佐剂"、"疫苗诱导的免疫反应 "和 "免疫原性 "等特定关键词。与处于临床前和临床开发阶段的候选疟疾疫苗没有直接关系的文章被排除在外:针对不同的寄生虫生命周期阶段,包括前红细胞期、红细胞期和性阶段,人们研究了多种疟疾疫苗开发方法。RTS、S/AS01 疫苗是首个达到世卫组织所列权威成熟度 4 级的人类寄生虫疫苗,在预防非洲儿童临床疟疾方面已证明有效。然而,在通过临床试验引入其他安全可行的疟疾疫苗方面进展缓慢。最近的研究强调了将红细胞前期疫苗和血期疫苗相结合的潜在有效性,以及用于预防和治疗的 mRNA 疫苗和用于大规模生产的非结构疫苗的优势:结论:针对寄生虫不同生命周期阶段的疟疾疫苗候选方案包括从化学预防接种到跨物种免疫保护。因此,在全球健康背景下,使用多抗原、多阶段组合疫苗至关重要。这就需要仔细了解和认真考虑影响疫苗诱导的整体免疫反应的免疫干扰、共支配、互补免疫反应、分子靶点和佐剂等多方面的长期相互作用。尽管存在挑战,但临床试验和疫苗接种技术的进步为疟疾疫苗开发的新方法提供了充满希望的可能性。
{"title":"A landscape review of malaria vaccine candidates in the pipeline.","authors":"Yusuf Amuda Tajudeen, Habeebullah Jayeola Oladipo, Sodiq Inaolaji Yusuff, Samuel O Abimbola, Muritala Abdulkadir, Iyiola Olatunji Oladunjoye, Abass Olawale Omotosho, Oluwaseyi Muyiwa Egbewande, Hameedat Damilola Shittu, Rashidat Onyinoyi Yusuf, Oluwatosin Ogundipe, Abdulbasit Opeyemi Muili, Abdullateef Opeyemi Afolabi, Salwa M A Dahesh, Marwa Ahmed Mahmoud Gameil, Mona Said El-Sherbini","doi":"10.1186/s40794-024-00222-3","DOIUrl":"10.1186/s40794-024-00222-3","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Globally, malaria continues to pose a major health challenge, with approximately 247 million cases of the illness and 627,000 deaths reported in 2021. However, the threat is particularly pronounced in sub-Saharan African countries, where pregnant women and children under the age of five face heightened vulnerability to the disease. As a result, the imperative to develop malaria vaccines especially for these vulnerable populations, remains crucial in the pursuit of malaria eradication. However, despite decades of research, effective vaccine development faces technical challenges, including the rapid spread of drug-resistant parasite strains, the complex parasite lifecycle, the development of liver hypnozoites with potential for relapse, and evasion of the host immune system. This review aims to discuss the different malaria vaccine candidates in the pipeline, highlighting different approaches used for adjuvating these candidates, their benefits, and outcomes, and summarizing the progress of these vaccine candidates under development.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Method: &lt;/strong&gt;A comprehensive web-based search for peer-reviewed journal articles published in SCOPUS, MEDLINE (via PubMed), Science Direct, WHO, and Advanced Google Scholar databases was conducted from 1990 to May 2022. Context-specific keywords such as \"Malaria\", \"Malaria Vaccine\", \"Malaria Vaccine Candidates\", \"Vaccine Development\", \"Vaccine Safety\", \"Clinical Trials\", \"mRNA Vaccines\", \"Viral Vector Vaccines\", \"Protein-based Vaccines\", \"Subunit Vaccines\", \"Vaccine Adjuvants\", \"Vaccine-induced Immune Responses\", and \"Immunogenicity\" were emphatically considered. Articles not directly related to malaria vaccine candidates in preclinical and clinical stages of development were excluded.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Various approaches have been studied for malaria vaccine development, targeting different parasite lifecycle stages, including the pre-erythrocytic, erythrocytic, and sexual stages. The RTS, S/AS01 vaccine, the first human parasite vaccine reaching WHO-listed authority maturity level 4, has demonstrated efficacy in preventing clinical malaria in African children. However, progress was slow in introducing other safe, and feasible malaria vaccines through clinical trials . Recent studies highlight the potential effectiveness of combining pre-erythrocytic and blood-stage vaccines, along with the advantages of mRNA vaccines for prophylaxis and treatment, and nonstructural vaccines for large-scale production.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Malaria vaccine candidates targeting different lifecycle stages of the parasite range from chemoprophylaxis vaccination to cross-species immune protection. The use of a multi-antigen, multi-stage combinational vaccine is therefore essential in the context of global health. This demands careful understanding and critical consideration of the long-term multi-faceted interplay of immune interference, co-dominance, complement","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"10 1","pages":"19"},"PeriodicalIF":2.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11293096/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141861040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterizing zero-dose and under-vaccinated children among refugees and internally displaced persons in the Democratic Republic of Congo. 刚果民主共和国难民和境内流离失所者中接种疫苗次数为零和不足的儿童的特征。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2024-07-15 DOI: 10.1186/s40794-024-00225-0
Marcellin Mengouo Nimpa, Aimé Cikomola Mwana-Wabene, John Otomba, Jean-Crispin Mukendi, M Carolina Danovaro-Holliday, Franck-Fortune Mboussou, Dieudonné Mwamba, Leandre Kambala, Dolla Ngwanga, Cedric Mwanga, Sume Gerald Etapelong, Issaka Compaoré, Moise Désiré Yapi, Daniel Katuashi Ishoso

Background: The Democratic Republic of Congo (DRC) has one of the highest numbers of un and under-vaccinated children as well as number of refugees and internally displaced persons (IDPs) in the world. This study aims to determine and compare the proportion and characteristics of zero-dose (ZD) and under-vaccinated (UV) children among refugees and IDPs in the DRC, as well as the reasons for incomplete vaccination schedules.

Methods: Data from a rolling vaccination coverage survey conducted from September 10, 2022, to July 03, 2023, among refugees and IDPs in 12 provinces of the DRC. ZD was defined as a child aged 12-23 months who had not received any dose of pentavalent vaccine DTP-Hib-Hep B (by card or recall) and UV as a child who had not received the third dose of pentavalent vaccine. The proportions of non and under-vaccination and the associated factors using a logistic regression model are presented for ZD and UV children. The reasons for non-vaccination of these children are described using the WHO-Immunization behavioral and social-drivers-conceptual framework and compared using Pearson's Chi2 test.

Results: Of 692 children aged 12 to 23 months included in the analysis, 9.3% (95% CI: 7.2-11.7%) were ZD and 40.9% (95% CI: 95%: 37.2-44.6%) UV. The Penta1/Penta3 drop-out rate was 34.9%. After adjustment, ZD children had a significant history of home or road birth. And UV children were significantly associated with mothers/caregivers being under 40, uneducated, farmers, ranchers, employed, rural residents, as well as with home or road births. Reasons linked to people's perceptions and feelings were cited much more often for ZD (50.0%) than for UV (38.3%). Those related to social reasons were cited much more often by ZD (40.6%) than by UV (35.7%). Reasons related to "programmatic and practical issues" were cited less for ZD (90.5%) than for UV (97.1%).

Conclusions: ZD and UV children represent significant proportions in refugee and IDPs sites in the DRC. However, the proportion of ZD is less than for the entire country, while the proportion of UV is comparable, reflected in a very high drop-out rate. Similarly to studies in the general population in DRC, the reasons for ZD children were mainly linked to challenges in caregiver motivation to vaccinate, while for UV children, they were more often linked to pro-grammatic and practical problems of the health system.

背景:刚果民主共和国(DRC)是世界上未接种疫苗和接种疫苗不足的儿童人数最多的国家之一,同时也是难民和境内流离失所者(IDP)人数最多的国家之一。本研究旨在确定和比较刚果(金)难民和国内流离失所者中零剂量(ZD)和接种不足(UV)儿童的比例和特征,以及疫苗接种计划不完整的原因:数据来自 2022 年 9 月 10 日至 2023 年 7 月 3 日对刚果民主共和国 12 个省的难民和境内流离失所者进行的滚动疫苗接种覆盖率调查。未接种ZD是指12-23个月的儿童未接种过任何剂量的五价疫苗白喉-百日咳-破伤风-乙肝(通过卡或召回),未接种UV是指未接种过第三剂五价疫苗。本报告采用逻辑回归模型列出了未接种和接种不足的比例以及与之相关的因素。使用世界卫生组织免疫行为和社会驱动因素概念框架描述了这些儿童未接种疫苗的原因,并使用 Pearson's Chi2 检验进行了比较:在纳入分析的 692 名 12 至 23 个月大的儿童中,9.3%(95% CI:7.2-11.7%)为 ZD,40.9%(95% CI:95%:37.2-44.6%)为 UV。Penta1/Penta3的辍学率为34.9%。经调整后,ZD 儿童有明显的家庭或道路分娩史。尿毒症患儿的母亲/照顾者年龄在 40 岁以下、未受过教育、农民、牧场主、受雇者、农村居民,以及在家或路上分娩都与尿毒症有关。与人们的看法和感受有关的原因在浙大(50.0%)比在紫外(38.3%)更常被提及。与社会原因有关的原因,ZD(40.6%)比 UV(35.7%)更多。与 "计划和实际问题 "有关的原因,零起点儿童(90.5%)的提及率低于普通儿童(97.1%):结论:在刚果(金)的难民和境内流离失所者营地中,ZD儿童和UV儿童占很大比例。结论:在刚果(金)的难民和境内流离失所者营地中,ZD 和 UV 儿童所占比例很大,但 ZD 儿童的比例低于全国儿童,而 UV 儿童的比例与全国儿童相当,这反映在极高的辍学率上。与对刚果(金)普通人群的研究类似,零接种儿童辍种的原因主要与照顾者接种疫苗的积极性有关,而未接种儿童辍种的原因则更多地与卫生系统的计划和实际问题有关。
{"title":"Characterizing zero-dose and under-vaccinated children among refugees and internally displaced persons in the Democratic Republic of Congo.","authors":"Marcellin Mengouo Nimpa, Aimé Cikomola Mwana-Wabene, John Otomba, Jean-Crispin Mukendi, M Carolina Danovaro-Holliday, Franck-Fortune Mboussou, Dieudonné Mwamba, Leandre Kambala, Dolla Ngwanga, Cedric Mwanga, Sume Gerald Etapelong, Issaka Compaoré, Moise Désiré Yapi, Daniel Katuashi Ishoso","doi":"10.1186/s40794-024-00225-0","DOIUrl":"10.1186/s40794-024-00225-0","url":null,"abstract":"<p><strong>Background: </strong>The Democratic Republic of Congo (DRC) has one of the highest numbers of un and under-vaccinated children as well as number of refugees and internally displaced persons (IDPs) in the world. This study aims to determine and compare the proportion and characteristics of zero-dose (ZD) and under-vaccinated (UV) children among refugees and IDPs in the DRC, as well as the reasons for incomplete vaccination schedules.</p><p><strong>Methods: </strong>Data from a rolling vaccination coverage survey conducted from September 10, 2022, to July 03, 2023, among refugees and IDPs in 12 provinces of the DRC. ZD was defined as a child aged 12-23 months who had not received any dose of pentavalent vaccine DTP-Hib-Hep B (by card or recall) and UV as a child who had not received the third dose of pentavalent vaccine. The proportions of non and under-vaccination and the associated factors using a logistic regression model are presented for ZD and UV children. The reasons for non-vaccination of these children are described using the WHO-Immunization behavioral and social-drivers-conceptual framework and compared using Pearson's Chi2 test.</p><p><strong>Results: </strong>Of 692 children aged 12 to 23 months included in the analysis, 9.3% (95% CI: 7.2-11.7%) were ZD and 40.9% (95% CI: 95%: 37.2-44.6%) UV. The Penta1/Penta3 drop-out rate was 34.9%. After adjustment, ZD children had a significant history of home or road birth. And UV children were significantly associated with mothers/caregivers being under 40, uneducated, farmers, ranchers, employed, rural residents, as well as with home or road births. Reasons linked to people's perceptions and feelings were cited much more often for ZD (50.0%) than for UV (38.3%). Those related to social reasons were cited much more often by ZD (40.6%) than by UV (35.7%). Reasons related to \"programmatic and practical issues\" were cited less for ZD (90.5%) than for UV (97.1%).</p><p><strong>Conclusions: </strong>ZD and UV children represent significant proportions in refugee and IDPs sites in the DRC. However, the proportion of ZD is less than for the entire country, while the proportion of UV is comparable, reflected in a very high drop-out rate. Similarly to studies in the general population in DRC, the reasons for ZD children were mainly linked to challenges in caregiver motivation to vaccinate, while for UV children, they were more often linked to pro-grammatic and practical problems of the health system.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"10 1","pages":"17"},"PeriodicalIF":2.4,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11247746/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141617136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018 -2023: a six-year retrospective study. 2018-2023年埃塞俄比亚提格雷中部肺结核推定患者的肺结核和利福平耐药性趋势:一项为期六年的回顾性研究。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2024-07-01 DOI: 10.1186/s40794-024-00224-1
Guesh Gebremariam, Mulugeta Kiros, Selemun Hagos, Haftom Hadush, Amaha Gebremichael, Gebretsadkan Gebrekirstos, Aregawi Tesfay, Teumelsan Gebrewahid, Tesfay Berihu, Brhane Gebremariam

Background: Tuberculosis (TB) is a major public health concern in the developing countries. Moreover, the emergence of multidrug-resistant tuberculosis is challenging. However, there are no organized data on the trends of pulmonary tuberculosis and rifampicin-resistant Mycobacterium tuberculosis in the study area.

Methods: A retrospective cross-sectional study was conducted to fill the information gap in Central Tigray at St. Mary General Hospital between 2018 and 2023. Data were collected from the GeneXpert™ tuberculosis registration logbooks using standard checklists and analyzed using Statistical Package for Social Science version 22. After performing logistic regression, a p-value < 0.05 with a corresponding 95% confidence interval was considered statistically significant. Moreover, chi square test for trend was performed to assess the percentage of annual detection of pulmonary tuberculosis and rifampicin-resistant Mycobacterium tuberculosis during the study years.

Result: Presumptive pulmonary tuberculosis patients with complete data (n = 3696) were included in the study. The overall prevalence of pulmonary tuberculosis was 11.7%, of which 8.1% were resistant to rifampicin. The study revealed that the incidence of pulmonary tuberculosis has been increasing, mainly in the recent four years. Likewise, an increase in rifampicin-resistant Mycobacterium tuberculosis was observed with considerable fluctuations. Age, human immunodeficiency virus infection, and presumptive rifampicin-resistant Mycobacterium tuberculosis infection were significantly associated with the presence of pulmonary tuberculosis. Moreover, pulmonary tuberculosis was more prevalent among participants in the productive-age group.

Conclusion: Although there have been fluctuations, an increasing of pulmonary tuberculosis and rifampicin-resistant Mycobacterium tuberculosis has been observed in recent years. Hence, prevention and treatment strategies for tuberculosis should be strengthened to alleviate the burden of pulmonary tuberculosis and rifampicin-resistant Mycobacterium tuberculosis in the study area.

背景:结核病(TB)是发展中国家主要的公共卫生问题。此外,耐多药结核病的出现也具有挑战性。然而,目前还没有关于研究地区肺结核和耐利福平结核分枝杆菌趋势的有组织数据:为了填补蒂格雷中部地区在 2018 年至 2023 年期间的信息空白,圣玛丽综合医院开展了一项回顾性横断面研究。使用标准核对表从 GeneXpert™ 结核病登记日志中收集数据,并使用社会科学统计软件包 22 版进行分析。在进行逻辑回归后,结果显示:P值为0:研究纳入了数据完整的推定肺结核患者(n = 3696)。肺结核的总发病率为 11.7%,其中 8.1%对利福平产生耐药性。研究显示,肺结核发病率一直在上升,主要是在最近四年。同样,耐利福平结核分枝杆菌的发病率也在上升,且波动较大。年龄、人体免疫缺陷病毒感染和推定的耐利福平结核分枝杆菌感染与肺结核的存在有显著相关性。此外,肺结核在生产年龄组的参与者中发病率更高:结论:近年来,肺结核和耐利福平结核分枝杆菌感染率虽有波动,但仍呈上升趋势。因此,应加强结核病的预防和治疗策略,以减轻研究地区肺结核和耐利福平结核分枝杆菌的负担。
{"title":"Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018 -2023: a six-year retrospective study.","authors":"Guesh Gebremariam, Mulugeta Kiros, Selemun Hagos, Haftom Hadush, Amaha Gebremichael, Gebretsadkan Gebrekirstos, Aregawi Tesfay, Teumelsan Gebrewahid, Tesfay Berihu, Brhane Gebremariam","doi":"10.1186/s40794-024-00224-1","DOIUrl":"10.1186/s40794-024-00224-1","url":null,"abstract":"<p><strong>Background: </strong>Tuberculosis (TB) is a major public health concern in the developing countries. Moreover, the emergence of multidrug-resistant tuberculosis is challenging. However, there are no organized data on the trends of pulmonary tuberculosis and rifampicin-resistant Mycobacterium tuberculosis in the study area.</p><p><strong>Methods: </strong>A retrospective cross-sectional study was conducted to fill the information gap in Central Tigray at St. Mary General Hospital between 2018 and 2023. Data were collected from the GeneXpert™ tuberculosis registration logbooks using standard checklists and analyzed using Statistical Package for Social Science version 22. After performing logistic regression, a p-value < 0.05 with a corresponding 95% confidence interval was considered statistically significant. Moreover, chi square test for trend was performed to assess the percentage of annual detection of pulmonary tuberculosis and rifampicin-resistant Mycobacterium tuberculosis during the study years.</p><p><strong>Result: </strong>Presumptive pulmonary tuberculosis patients with complete data (n = 3696) were included in the study. The overall prevalence of pulmonary tuberculosis was 11.7%, of which 8.1% were resistant to rifampicin. The study revealed that the incidence of pulmonary tuberculosis has been increasing, mainly in the recent four years. Likewise, an increase in rifampicin-resistant Mycobacterium tuberculosis was observed with considerable fluctuations. Age, human immunodeficiency virus infection, and presumptive rifampicin-resistant Mycobacterium tuberculosis infection were significantly associated with the presence of pulmonary tuberculosis. Moreover, pulmonary tuberculosis was more prevalent among participants in the productive-age group.</p><p><strong>Conclusion: </strong>Although there have been fluctuations, an increasing of pulmonary tuberculosis and rifampicin-resistant Mycobacterium tuberculosis has been observed in recent years. Hence, prevention and treatment strategies for tuberculosis should be strengthened to alleviate the burden of pulmonary tuberculosis and rifampicin-resistant Mycobacterium tuberculosis in the study area.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"10 1","pages":"15"},"PeriodicalIF":2.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11215829/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141471005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the utilization and perceptions of pre-travel health consultations in primary care settings in Saudi Arabia: a cross-sectional study. 探索沙特阿拉伯初级保健机构对旅行前健康咨询的利用和看法:一项横断面研究。
IF 3.1 Q3 INFECTIOUS DISEASES Pub Date : 2024-06-15 DOI: 10.1186/s40794-024-00223-2
Naheel A AlAmer, Amani M AlQarni

Background: International travel exposes individuals to diverse health risks, necessitating proactive pre-travel health preparations. Saudi Arabia has witnessed increased outbound travel. This study addresses a critical gap in knowledge by investigating the utilization and perceptions of pre-travel health consultations among adults in the Eastern Province of Saudi Arabia.

Methods: This cross-sectional study surveyed patients at the Family and Community Medicine Center of Imam Abdulrahman Bin Faisal University during January 2024 to explore perceptions of pre-travel health consultations among the Saudi Arabian population. Adults aged 18 years or older in the waiting area were invited to complete a self-administered questionnaire.

Results: Of the 772 participants, 624 (80.8%) engaged in international travel within the last year. However, 593 (76.8%) had never sought pre-travel health consultations. Age, gender, and education level significantly influenced the pursuit of pre-travel health advice, with older individuals, females, and those with higher educational attainment more likely to seek consultations. Participants perceived vaccination recommendations (597, 77.4%) and disease prevention information (678, 87.8%) as crucial parts of pre-travel health consultations. However, barriers to seeking advice included perceived low risk (445, 74.8%), lack of awareness (215, 36.3%), time constraints (128, 21.6%), and cost concerns (92, 15.5%).

Conclusion: The low prevalence of pre-travel health consultations among travelers highlights the need for targeted educational campaigns and the integration of travel health services into primary healthcare. Addressing the identified barriers and leveraging preferred information sources are crucial steps towards enhancing the uptake of pre-travel health consultations, ultimately improving the health and safety of international travelers from the region.

背景:国际旅行使个人面临各种健康风险,因此需要积极做好旅行前的健康准备。沙特阿拉伯的出境游日益增多。本研究通过调查沙特阿拉伯东部省成年人对旅行前健康咨询的利用情况和看法,填补了这一重要的知识空白:这项横断面研究于 2024 年 1 月对伊玛目-阿卜杜勒拉赫曼-本-费萨尔大学家庭和社区医学中心的患者进行了调查,以了解沙特阿拉伯人对旅行前健康咨询的看法。候诊区内年满 18 岁的成年人受邀填写了一份自填问卷:在 772 名参与者中,有 624 人(80.8%)在过去一年中进行过国际旅行。然而,有 593 人(76.8%)从未进行过旅行前健康咨询。年龄、性别和教育程度对寻求旅行前健康咨询有很大影响,年龄较大者、女性和教育程度较高者更有可能寻求咨询。参与者认为疫苗接种建议(597 人,77.4%)和疾病预防信息(678 人,87.8%)是旅行前健康咨询的重要组成部分。然而,寻求建议的障碍包括认为风险低(445 人,占 74.8%)、缺乏认识(215 人,占 36.3%)、时间限制(128 人,占 21.6%)和费用问题(92 人,占 15.5%):旅行者进行旅行前健康咨询的比例较低,这突出表明有必要开展有针对性的教育活动,并将旅行健康服务纳入初级医疗保健中。消除已发现的障碍和利用首选信息来源是提高旅行前健康咨询普及率的关键步骤,最终将改善该地区国际旅行者的健康和安全。
{"title":"Exploring the utilization and perceptions of pre-travel health consultations in primary care settings in Saudi Arabia: a cross-sectional study.","authors":"Naheel A AlAmer, Amani M AlQarni","doi":"10.1186/s40794-024-00223-2","DOIUrl":"10.1186/s40794-024-00223-2","url":null,"abstract":"<p><strong>Background: </strong>International travel exposes individuals to diverse health risks, necessitating proactive pre-travel health preparations. Saudi Arabia has witnessed increased outbound travel. This study addresses a critical gap in knowledge by investigating the utilization and perceptions of pre-travel health consultations among adults in the Eastern Province of Saudi Arabia.</p><p><strong>Methods: </strong>This cross-sectional study surveyed patients at the Family and Community Medicine Center of Imam Abdulrahman Bin Faisal University during January 2024 to explore perceptions of pre-travel health consultations among the Saudi Arabian population. Adults aged 18 years or older in the waiting area were invited to complete a self-administered questionnaire.</p><p><strong>Results: </strong>Of the 772 participants, 624 (80.8%) engaged in international travel within the last year. However, 593 (76.8%) had never sought pre-travel health consultations. Age, gender, and education level significantly influenced the pursuit of pre-travel health advice, with older individuals, females, and those with higher educational attainment more likely to seek consultations. Participants perceived vaccination recommendations (597, 77.4%) and disease prevention information (678, 87.8%) as crucial parts of pre-travel health consultations. However, barriers to seeking advice included perceived low risk (445, 74.8%), lack of awareness (215, 36.3%), time constraints (128, 21.6%), and cost concerns (92, 15.5%).</p><p><strong>Conclusion: </strong>The low prevalence of pre-travel health consultations among travelers highlights the need for targeted educational campaigns and the integration of travel health services into primary healthcare. Addressing the identified barriers and leveraging preferred information sources are crucial steps towards enhancing the uptake of pre-travel health consultations, ultimately improving the health and safety of international travelers from the region.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"10 1","pages":"13"},"PeriodicalIF":3.1,"publicationDate":"2024-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11179328/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141321716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tetanus- a case report highlighting the challenges in diagnosis and treatment. 破伤风--病例报告凸显诊断和治疗的挑战。
IF 3.1 Q3 INFECTIOUS DISEASES Pub Date : 2024-06-01 DOI: 10.1186/s40794-024-00220-5
Menno Boer, Martijn de Voogd, Nicolasine Diana Niemeijer, Lonneke van Hoeven

Tetanus has become an increasingly rare infectious disease due to the development of successful vaccination programs in the mid-20th century. In resource-rich countries, mainly unvaccinated or partly vaccinated risk groups are affected, whereas tetanus still remains prevalent in resource-limited countries. The decreasing incidence in developed countries has hindered clinical trials evaluating the best treatment modalities for tetanus infections. Current guidelines are based on a small number of studies and case reports. So far, these studies have shown potential benefits of treating tetanus infections with benzodiazepines, magnesium sulfate and baclofen. Additionally, several treatments have been shown to be useful in stabilizing and supporting patients with tetanus. However, each treatment modality has limitations, from negative side effects to logistical challenges, especially in developing countries. Therefore, further knowledge is required to evaluate the best use of each treatment and to further optimize patient care. This knowledge can contribute to the reduction of the burden of disease in countries where tetanus remains prevalent and where resources are limited, though vaccination is the most effective method to achieve this. This case report describes the treatment of a Dutch patient with tetanus infection and illustrates the role of benzodiazepines as well as other key aspects of treating patients with tetanus.

由于 20 世纪中期疫苗接种计划的成功发展,破伤风已成为一种越来越罕见的传染病。在资源丰富的国家,受影响的主要是未接种疫苗或部分接种疫苗的高危人群,而在资源有限的国家,破伤风仍很流行。发达国家破伤风发病率的下降阻碍了评估破伤风感染最佳治疗方法的临床试验。目前的指导方针是基于少量的研究和病例报告。迄今为止,这些研究显示了使用苯二氮卓、硫酸镁和巴氯芬治疗破伤风感染的潜在益处。此外,还有几种治疗方法被证明有助于稳定和支持破伤风患者。然而,每种治疗方法都有其局限性,从负面副作用到后勤挑战,尤其是在发展中国家。因此,我们需要更多的知识来评估每种治疗方法的最佳应用,并进一步优化患者护理。在破伤风仍然流行且资源有限的国家,这些知识有助于减轻疾病负担,尽管接种疫苗是实现这一目标的最有效方法。本病例报告描述了对一名荷兰破伤风感染患者的治疗,并说明了苯二氮卓类药物的作用以及治疗破伤风患者的其他关键方面。
{"title":"Tetanus- a case report highlighting the challenges in diagnosis and treatment.","authors":"Menno Boer, Martijn de Voogd, Nicolasine Diana Niemeijer, Lonneke van Hoeven","doi":"10.1186/s40794-024-00220-5","DOIUrl":"10.1186/s40794-024-00220-5","url":null,"abstract":"<p><p>Tetanus has become an increasingly rare infectious disease due to the development of successful vaccination programs in the mid-20th century. In resource-rich countries, mainly unvaccinated or partly vaccinated risk groups are affected, whereas tetanus still remains prevalent in resource-limited countries. The decreasing incidence in developed countries has hindered clinical trials evaluating the best treatment modalities for tetanus infections. Current guidelines are based on a small number of studies and case reports. So far, these studies have shown potential benefits of treating tetanus infections with benzodiazepines, magnesium sulfate and baclofen. Additionally, several treatments have been shown to be useful in stabilizing and supporting patients with tetanus. However, each treatment modality has limitations, from negative side effects to logistical challenges, especially in developing countries. Therefore, further knowledge is required to evaluate the best use of each treatment and to further optimize patient care. This knowledge can contribute to the reduction of the burden of disease in countries where tetanus remains prevalent and where resources are limited, though vaccination is the most effective method to achieve this. This case report describes the treatment of a Dutch patient with tetanus infection and illustrates the role of benzodiazepines as well as other key aspects of treating patients with tetanus.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"10 1","pages":"10"},"PeriodicalIF":3.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11143707/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141187060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood smears examination and prevalence of malaria in Addis Zemen Town, Northwest Ethiopia (2013-2021): a retrospective study. 埃塞俄比亚西北部亚的斯亚贝巴泽门镇的血液涂片检查和疟疾流行情况(2013-2021 年):一项回顾性研究。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2024-05-15 DOI: 10.1186/s40794-024-00219-y
Tilahun Adugna, Lamesgin Zelalem, Gedafaw Alelign

Introduction: In Ethiopia, malaria is one of the major public health and socioeconomic problems, though tremendous efforts have been made. Currently, the country has a plan to eliminate malaria by 2030. To achieve this plan, epidemiological studies associated with malaria prevalence with gender, age groups, species types, and seasons are essential. Therefore, the aim of this study was to assess the prevalence of malaria from 2013 to 2021 in Addis Zemen town, Northwest Ethiopia.

Methods: A retrospective study was conducted at assess the trend of malaria prevalence over the last nine years using recorded blood smear reports in the laboratory logbook from governmental health institutions. Trends in malaria cases and the proportion of genders, age groups, species, and seasons over time were compared. The data were analyzed using the SPSS-23 software package.

Results: The overall malaria prevalence between 2013 and 2021 was 10.4%. From all confirmed cases, the minimum and maximum prevalence of malaria cases were recorded in 2018 (2%) and 2016 (33.2%) years, respectively. The infectious rate of males (59.3%) was significantly higher than that of females (40.7%) (p < 0.0001). In all survey periods, all age groups were infected by malaria parasites; the majority of the cases were between 15 and 45 years (57%) older than others. Statistically, a greater proportion of P. falciparum (80.1%) was recorded than P. vivax (18.5%) (p < 0.0001). Malaria cases were occurring throughout each month. The relative highest peaks of total malaria cases were observed during the months of September, October, and November. Seasonally, the highest infection rate was observed during spring (40.20%) compared to other seasons.

Conclusions: In conclusion, the study revealed that malaria transmission remained high, which affected males more than females and potentially reproductive ages. Two of the most important Plasmodium species were identified and found during all reviewed months and years, though P. falciparum was the most prevalent. Hence, the problem can be alleviated by using season-based long-lasting insecticide treated nets, regularly overseeing ongoing irrigation activity, overseeing the reduction of the water level of the Sheni River, health education, and providing immediate patient treatment.

导言:在埃塞俄比亚,疟疾是主要的公共卫生和社会经济问题之一,尽管该国已做出巨大努力。目前,该国已制定了到 2030 年消除疟疾的计划。为了实现这一计划,必须对疟疾流行率与性别、年龄组、物种类型和季节进行相关的流行病学研究。因此,本研究旨在评估 2013 年至 2021 年埃塞俄比亚西北部亚的斯亚贝巴泽门镇的疟疾流行情况:这项回顾性研究利用政府卫生机构实验室日志中记录的血涂片报告,对过去九年的疟疾流行趋势进行了评估。研究人员比较了疟疾病例的变化趋势以及不同性别、年龄组、种类和季节的比例。数据使用 SPSS-23 软件包进行分析:结果:2013 年至 2021 年间,疟疾的总体发病率为 10.4%。在所有确诊病例中,2018 年(2%)和 2016 年(33.2%)分别记录了疟疾病例的最低和最高流行率。男性的感染率(59.3%)明显高于女性(40.7%)(p 结论):总之,研究表明,疟疾传播率仍然很高,男性比女性更容易感染,而且可能会影响到育龄人群。尽管恶性疟原虫是最常见的疟原虫,但在所有审查月份和年份中都发现了两种最重要的疟原虫。因此,可以通过使用以季节为基础的长效驱虫蚊帐、定期监督正在进行的灌溉活动、监督谢尼河水位的降低、健康教育以及为病人提供及时治疗来缓解这一问题。
{"title":"Blood smears examination and prevalence of malaria in Addis Zemen Town, Northwest Ethiopia (2013-2021): a retrospective study.","authors":"Tilahun Adugna, Lamesgin Zelalem, Gedafaw Alelign","doi":"10.1186/s40794-024-00219-y","DOIUrl":"10.1186/s40794-024-00219-y","url":null,"abstract":"<p><strong>Introduction: </strong>In Ethiopia, malaria is one of the major public health and socioeconomic problems, though tremendous efforts have been made. Currently, the country has a plan to eliminate malaria by 2030. To achieve this plan, epidemiological studies associated with malaria prevalence with gender, age groups, species types, and seasons are essential. Therefore, the aim of this study was to assess the prevalence of malaria from 2013 to 2021 in Addis Zemen town, Northwest Ethiopia.</p><p><strong>Methods: </strong>A retrospective study was conducted at assess the trend of malaria prevalence over the last nine years using recorded blood smear reports in the laboratory logbook from governmental health institutions. Trends in malaria cases and the proportion of genders, age groups, species, and seasons over time were compared. The data were analyzed using the SPSS-23 software package.</p><p><strong>Results: </strong>The overall malaria prevalence between 2013 and 2021 was 10.4%. From all confirmed cases, the minimum and maximum prevalence of malaria cases were recorded in 2018 (2%) and 2016 (33.2%) years, respectively. The infectious rate of males (59.3%) was significantly higher than that of females (40.7%) (p < 0.0001). In all survey periods, all age groups were infected by malaria parasites; the majority of the cases were between 15 and 45 years (57%) older than others. Statistically, a greater proportion of P. falciparum (80.1%) was recorded than P. vivax (18.5%) (p < 0.0001). Malaria cases were occurring throughout each month. The relative highest peaks of total malaria cases were observed during the months of September, October, and November. Seasonally, the highest infection rate was observed during spring (40.20%) compared to other seasons.</p><p><strong>Conclusions: </strong>In conclusion, the study revealed that malaria transmission remained high, which affected males more than females and potentially reproductive ages. Two of the most important Plasmodium species were identified and found during all reviewed months and years, though P. falciparum was the most prevalent. Hence, the problem can be alleviated by using season-based long-lasting insecticide treated nets, regularly overseeing ongoing irrigation activity, overseeing the reduction of the water level of the Sheni River, health education, and providing immediate patient treatment.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"10 1","pages":"12"},"PeriodicalIF":2.4,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11095033/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140923457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"We were leery of going": qualitatively exploring Canadian international retirement migrants' travel-related decisions during the COVID-19 pandemic. "我们不敢去":定性探讨加拿大国际退休移民在 COVID-19 大流行期间做出的与旅行相关的决定。
IF 3.1 Q3 INFECTIOUS DISEASES Pub Date : 2024-05-01 DOI: 10.1186/s40794-024-00218-z
Jessica Tate, Valorie A Crooks, Jeremy Snyder
<p><strong>Background: </strong>International retirement migration, which is the seasonal or permanent relocation of older people to another country, has grown in popularity in recent years. These retirees are motivated by the promise of warmer winter climates that are conducive to participating in health-promoting recreational and social activities. Ease of cross-border travel facilitates this transnational practice when undertaken seasonally. However, border closures and other travel-related measures put in place to manage the spread of COVID-19, disrupted travel, including for older Canadians who typically winter in the United States (US). During the 2020-21 winter season, for example, Canadians were advised not to engage in non-essential international travel and the land border between Canada and the US was closed to all but essential travellers. Nonetheless, retirement migration remained a significant draw for many Canadian retirees. Here, we qualitatively explore the factors that Canadian international retirement migrants considered when deciding whether or not to travel to the US for the 2020-21 winter during the COVID-19 pandemic.</p><p><strong>Methods: </strong>Guided by case study methodology, semi-structured interviews were conducted with 31 Canadian international retirement migrants who had wintered in the US prior to the COVID-19 pandemic and were in the US at the outset of the pandemic in late winter 2020. Interviews were transcribed verbatim and thematically analyzed to decipher what factors were most important to their travel-related decision-making during the pandemic. We structure the thematic results around four factors previously identified to motivate older people to become international retirement migrants and thus inform decision-making: the destination, the people, the cost, and the movement.</p><p><strong>Results: </strong>The previously identified factors that motivate older people to participate in international retirement migration include: the destination (e.g., climate and amenities), the people (e.g., social networks), the cost (e.g., health insurance and living costs), and the movement (e.g., ease of travel). These factors informed how international retirement migrants made decisions to travel abroad or not in the 2020-21 winter season. For example, destination-based factors included a lack of public health measures and high case counts, people-based factors comprised of less opportunities to engage in social activities, cost-based factors involved maintaining property investments and the lack of COVID-19 treatment coverage in available travel health insurance plans, and movement-based factors included challenges in ease of access when travel was viewed as essential or non-essential. These factors disincentivized or motivated international retirement migrants to travel abroad in the 2020-21 winter season during the COVID-19 pandemic.</p><p><strong>Conclusions: </strong>The results of this study support the need to
背景:国际退休移民是指老年人季节性或永久性地迁移到另一个国家,近年来越来越受欢迎。这些退休人员的动机是,冬季气候温暖,有利于他们参加促进健康的娱乐和社交活动。跨境旅行的便利为这种季节性跨国旅行提供了便利。然而,为控制 COVID-19 的传播而实施的边境关闭和其他旅行相关措施扰乱了旅行,包括通常在美国过冬的加拿大老年人。例如,在 2020-21 年冬季,加拿大人被建议不要进行非必要的国际旅行,加拿大和美国之间的陆地边界除必要的旅行者外,对所有旅行者关闭。尽管如此,退休移民对许多加拿大退休人员来说仍然具有重要的吸引力。在此,我们从定性角度探讨了加拿大国际退休移民在决定是否在 COVID-19 大流行期间于 2020-21 年冬季前往美国时所考虑的因素:在案例研究方法的指导下,我们对 31 名加拿大国际退休移民进行了半结构化访谈,他们在 COVID-19 大流行之前曾在美国过冬,并在 2020 年冬末大流行开始时在美国。我们对访谈内容进行了逐字记录和专题分析,以解读在大流行期间哪些因素对他们的旅行相关决策最为重要。我们围绕之前确定的促使老年人成为国际退休移民的四个因素进行专题分析,从而为决策提供参考:目的地、人员、成本和行动:先前确定的促使老年人参与国际退休移民的因素包括:目的地(如气候和便利设施)、人员(如社交网络)、成本(如医疗保险和生活费用)以及迁移(如旅行便利性)。这些因素为国际退休移民在 2020-21 年冬季决定是否出国旅行提供了依据。例如,目的地因素包括缺乏公共卫生措施和高病例数,人员因素包括参与社会活动的机会较少,成本因素包括维持财产投资和现有旅行医疗保险计划中缺乏 COVID-19 治疗范围,而行动因素包括在旅行被视为必要或非必要时,在交通便利性方面面临的挑战。这些因素抑制或促使国际退休移民在 2020-21 年冬季 COVID-19 大流行期间出国旅行:本研究的结果证明,有必要为国际退休移民创建量身定制的决策支持工具,以便他们在危机事件期间做出与旅行相关的明智决定,从而保护他们的健康和福祉。还需要开展更多研究,探讨国际退休移民对风险,尤其是健康风险的认识,以及这些认识如何以不同方式影响他们的旅行相关决策。
{"title":"\"We were leery of going\": qualitatively exploring Canadian international retirement migrants' travel-related decisions during the COVID-19 pandemic.","authors":"Jessica Tate, Valorie A Crooks, Jeremy Snyder","doi":"10.1186/s40794-024-00218-z","DOIUrl":"https://doi.org/10.1186/s40794-024-00218-z","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;International retirement migration, which is the seasonal or permanent relocation of older people to another country, has grown in popularity in recent years. These retirees are motivated by the promise of warmer winter climates that are conducive to participating in health-promoting recreational and social activities. Ease of cross-border travel facilitates this transnational practice when undertaken seasonally. However, border closures and other travel-related measures put in place to manage the spread of COVID-19, disrupted travel, including for older Canadians who typically winter in the United States (US). During the 2020-21 winter season, for example, Canadians were advised not to engage in non-essential international travel and the land border between Canada and the US was closed to all but essential travellers. Nonetheless, retirement migration remained a significant draw for many Canadian retirees. Here, we qualitatively explore the factors that Canadian international retirement migrants considered when deciding whether or not to travel to the US for the 2020-21 winter during the COVID-19 pandemic.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Guided by case study methodology, semi-structured interviews were conducted with 31 Canadian international retirement migrants who had wintered in the US prior to the COVID-19 pandemic and were in the US at the outset of the pandemic in late winter 2020. Interviews were transcribed verbatim and thematically analyzed to decipher what factors were most important to their travel-related decision-making during the pandemic. We structure the thematic results around four factors previously identified to motivate older people to become international retirement migrants and thus inform decision-making: the destination, the people, the cost, and the movement.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The previously identified factors that motivate older people to participate in international retirement migration include: the destination (e.g., climate and amenities), the people (e.g., social networks), the cost (e.g., health insurance and living costs), and the movement (e.g., ease of travel). These factors informed how international retirement migrants made decisions to travel abroad or not in the 2020-21 winter season. For example, destination-based factors included a lack of public health measures and high case counts, people-based factors comprised of less opportunities to engage in social activities, cost-based factors involved maintaining property investments and the lack of COVID-19 treatment coverage in available travel health insurance plans, and movement-based factors included challenges in ease of access when travel was viewed as essential or non-essential. These factors disincentivized or motivated international retirement migrants to travel abroad in the 2020-21 winter season during the COVID-19 pandemic.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The results of this study support the need to ","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"10 1","pages":"9"},"PeriodicalIF":3.1,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11062001/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140852821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges of diagnosing severe malaria with complications in adult patients: a case report. 诊断成年重症疟疾并发症的挑战:病例报告。
IF 3.1 Q3 INFECTIOUS DISEASES Pub Date : 2024-04-01 DOI: 10.1186/s40794-023-00216-7
Rika Bur, Erni Juwita Nelwan, Ira Danasasmita, Gardian Lukman Hakim, Syukrini Bahri, Febby Elvanesa Sandra Dewi, Rana Zara Athaya, Leonard Nainggolan

Background: Malaria is known to be the main cause of death in malaria-endemic areas. The authors report a case of severe malaria in an adult with no history of travel from an endemic area with good outcomes after hospitalization.

Case presentation: A 46-year-old man was brought to the Emergency Room (ER) because of fever and chills for 6 days. Complaints were accompanied by nausea and vomiting three times a day. The patient also experienced headaches, weakness, coughing, and a runny nose after two days of admission. The patient had no history of traveling from a malaria-endemic area. The patient was transferred from the Emergency Department (ED) to the High Care Unit (HCU), and during 1 day of intensive care at the HCU, there was a clinical deterioration characterized by dyspnea, icteric sclerae, acral edema, tenderness in both calves, and rash in the abdominal area. Due to worsening respiratory function, the patient was placed on a ventilator. During intensive treatment, the patient continued to show deterioration. The clinical findings suggested a possible feature of Weil's disease or fulminant hepatitis, and although the patient was in intensive care, there was no clinically significant improvement. Furthermore, microscopic blood smear examination and rapid diagnostic tests (RDTs) for malaria were carried out on the 4th day of treatment with negative results. As there was no clinically significant improvement, it was decided to take a blood smear and repeat RDT on the twelfth day, which showed a positive result for falciparum malaria. Subsequently, artesunate was administered intravenously, and the patient's condition began to improve with a negative parasite count the following day. The patient was discharged in good clinical condition on day 25 of treatment.

Conclusion: Good quality malaria diagnostic techniques are essential to diagnose malaria. A timely diagnosis of malaria has the potential to save the patient. Because Jakarta is not a malaria endemic area, it was concluded that this case was an introduced malaria case.

背景:众所周知,疟疾是疟疾流行地区的主要死因。作者报告了一例无疟疾流行地区旅行史的成人重症疟疾病例,住院治疗后效果良好:一名 46 岁的男子因连续 6 天发烧和发冷被送到急诊室。患者伴有恶心和呕吐,每天三次。入院两天后,患者还出现头痛、乏力、咳嗽和流鼻涕。患者没有从疟疾流行地区出过远门的病史。患者从急诊科(ED)转入重症监护室(HCU),在重症监护室接受重症监护 1 天期间,患者的临床症状出现恶化,表现为呼吸困难、巩膜结冰、口角水肿、双小腿触痛和腹部皮疹。由于呼吸功能恶化,患者被安置在呼吸机上。在强化治疗期间,患者病情继续恶化。临床结果表明,患者可能患有韦氏病或暴发性肝炎,虽然患者一直在接受重症监护,但临床症状并没有明显改善。此外,在治疗的第 4 天进行了显微血涂片检查和疟疾快速诊断检测(RDT),结果均为阴性。由于临床症状没有明显改善,因此决定在第 12 天进行血液涂片检查和快速诊断检测,结果显示恶性疟原虫疟疾呈阳性。随后,患者接受了青蒿琥酯静脉注射,第二天寄生虫计数为阴性,病情开始好转。治疗第 25 天,患者出院时临床状况良好:结论:高质量的疟疾诊断技术对于诊断疟疾至关重要。结论:高质量的疟疾诊断技术对疟疾诊断至关重要,及时诊断疟疾有可能挽救病人。由于雅加达不是疟疾流行区,因此可以断定该病例是一个外来疟疾病例。
{"title":"Challenges of diagnosing severe malaria with complications in adult patients: a case report.","authors":"Rika Bur, Erni Juwita Nelwan, Ira Danasasmita, Gardian Lukman Hakim, Syukrini Bahri, Febby Elvanesa Sandra Dewi, Rana Zara Athaya, Leonard Nainggolan","doi":"10.1186/s40794-023-00216-7","DOIUrl":"10.1186/s40794-023-00216-7","url":null,"abstract":"<p><strong>Background: </strong>Malaria is known to be the main cause of death in malaria-endemic areas. The authors report a case of severe malaria in an adult with no history of travel from an endemic area with good outcomes after hospitalization.</p><p><strong>Case presentation: </strong>A 46-year-old man was brought to the Emergency Room (ER) because of fever and chills for 6 days. Complaints were accompanied by nausea and vomiting three times a day. The patient also experienced headaches, weakness, coughing, and a runny nose after two days of admission. The patient had no history of traveling from a malaria-endemic area. The patient was transferred from the Emergency Department (ED) to the High Care Unit (HCU), and during 1 day of intensive care at the HCU, there was a clinical deterioration characterized by dyspnea, icteric sclerae, acral edema, tenderness in both calves, and rash in the abdominal area. Due to worsening respiratory function, the patient was placed on a ventilator. During intensive treatment, the patient continued to show deterioration. The clinical findings suggested a possible feature of Weil's disease or fulminant hepatitis, and although the patient was in intensive care, there was no clinically significant improvement. Furthermore, microscopic blood smear examination and rapid diagnostic tests (RDTs) for malaria were carried out on the 4th day of treatment with negative results. As there was no clinically significant improvement, it was decided to take a blood smear and repeat RDT on the twelfth day, which showed a positive result for falciparum malaria. Subsequently, artesunate was administered intravenously, and the patient's condition began to improve with a negative parasite count the following day. The patient was discharged in good clinical condition on day 25 of treatment.</p><p><strong>Conclusion: </strong>Good quality malaria diagnostic techniques are essential to diagnose malaria. A timely diagnosis of malaria has the potential to save the patient. Because Jakarta is not a malaria endemic area, it was concluded that this case was an introduced malaria case.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"10 1","pages":"7"},"PeriodicalIF":3.1,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10983720/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140331994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Tropical Diseases, Travel Medicine and Vaccines
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1